June 28, 2022
Contrast media shortage reveals cracks in supply chain
May 2022 saw a critical shortage of the iodinated contrast medium (ICM) iohexol that extended well into June because of a COVID-19-related shutdown of a GE Healthcare plant in Shanghai, China, that interrupted the manufacture of ICM. According to the American College of Radiology, contrast media were added to the US Food and Drug Administration (FDA) drug shortage list on May 9.
Free Daily News
- Value assessment of a trauma hybrid OR
- SHEA: Strategies to prevent SSIs updated
- FDA: Class I recall of Draeger Medical’s Seattle PAP Plus, breathing circuit/anesthesia kits
- Surgeon-scientists represent less than 2% of all investigators awarded NIH funding
- New EHR generative AI by Microsoft, Epic currently being piloted
- Development of a definition for long COVID
- The Joint Commission seeking comments on proposed new infection control requirements for hospitals, critical access hospitals
- Using human-AI collaboration to monitor PPE donning, doffing
- The Joint Commission: Licensed independent practitioner term eliminated from AHC, OBS accreditation programs
- Projected growth of nursing, OR-related occupations 2021-2031
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity